Enhance your nephrology practice with CME and tools focused on kidney medicine.
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
Implementing the SOC Induction Therapies in AAV
Silke R. Brix, MD, MRCP, SCPR
Bernhard Hellmich, MD
Preserving Renal Function in AAV: From Novel Therapies to Practice-Changing Strategies
June 06, 2025
Vienna
Managing Patients With AAV in the Rheumatology Clinic
Andreas Kronbichler, MD
Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
Mikhail Kosiborod, MD
Stephen J. Greene, MD, FACC, FHFSA
Unmasking IgAN: From Suspicion to Timely Diagnosis
Jörg Latus, MD
Chee Kay Cheung, MBCHB, MRCP, PHD
Achieving Optimal Outcomes in Lupus Nephritis: Key Updates from the 2024 ACR Guidelines
Robin Dore, MD
Finally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
Don't Miss It! Rapid & Accurate AAV Diagnosis
Optimizing AAV Outcomes: Maintenance Therapies
Pearls of Wisdom: Optimizing Hyperkalemia Management in Patients with CKD
Matthew R. Weir, MD
Nihar Desai, MD
Ellie Kelepouris, MD, FACP, FAHA
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Advances in IgAN Care From Kidney Week
Sydney Tang, MBBS, MD
Optimizing Outcomes in Patients With IgAN: Novel Therapies and Evolving Guidelines
Jürgen Floege, PhD
Jonathan Barratt, PhD
Current Experiences in Identifying and Treating Itch in Patients on Hemodialysis
James Burton, DM, FRCP
Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS
Advancing IgAN Care: Expert Strategies for Transformative Patient Outcomes
Jurgen Floege MD
Uyen Huynh-Do, MD
Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution
Elevating Care for Patients With Severe Renal Disease in AAV
Revolutionizing IgAN Care in the Era of Precision Medicine: Diagnostic Approaches, Evolving Guidelines, and Novel Therapies
June 05, 2025
Partnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
David Wheeler, MB, CHB, MD, FRCP
Call to Action: Utilizing Avacopan to Improve AAV Care
Stephen McAdoo, MD
Achieving Success in IgAN & FSGS
Siân Griffin, MD, PhD
Loreto Gesualdo, MD, FERA
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
Thilo Krüger, MD, PhD
Steven Fishbane, MD
Lucio Manenti, MD, PhD
Can We Do Better in IgAN?
Annette Bruchfeld, MD, PhD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.